Robert Ho's most recent trade in Nike, Inc. - Ordinary Shares - Class B was a trade of 8,691 Class B Common Stock done at an average price of $57.5 . Disclosure was reported to the exchange on Dec. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nike | Robert Holmes Swan | Director | Purchase of securities on an exchange or from another person at price $ 57.54 per share. | 22 Dec 2025 | 8,691 | 43,293 (0%) | 0% | 57.5 | 500,080 | Class B Common Stock |
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.35 per share. | 19 Dec 2025 | 1,000 | 4,026 | - | 17.4 | 17,350 | Common Stock |
| CF Bankshares Inc | Robert E. Hoeweler | Director | Purchase of securities on an exchange or from another person at price $ 23.87 per share. | 15 Dec 2025 | 1,000 | 72,062 (1%) | 0% | 23.9 | 23,870 | Common Stock 12520L 109 |
| ADP | Robert Holmes Swan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 1,453 | 1,453 (0%) | 0% | 0 | Common Stock | |
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 7,230,283 | 0 | - | - | Series A Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 7,145,647 | 0 | - | - | Series Seed Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 3,572,816 | 0 | - | - | Series Seed Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 2,582,243 | 0 | - | - | Series A Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 2,508,575 | 0 | - | - | Series C Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 2,104,740 | 0 | - | - | Series B Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 1,895,260 | 0 | - | - | Series B Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 1,632,441 | 1,632,441 | - | - | Common Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 1,441,032 | 1,441,032 | - | - | Common Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 313,571 | 0 | - | - | Series C Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 313,571 | 0 | - | - | Series C Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 294,502 | 294,502 | - | - | Common Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 25,790 | 0 | - | - | Series Seed Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 3,026 | 3,026 | - | - | Common Stock | ||
| Northwestern Corp | Jan Robert Horsfall | Director | Grant, award, or other acquisition of securities at price $ 58.61 per share. | 04 Nov 2025 | 640 | 9,896 (0%) | 0% | 58.6 | 37,510 | Common Stock |
| Micron Tech | Robert Holmes Swan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2025 | 1,377 | 1,377 | - | - | Restricted Stock Units | |
| Micron Tech | Robert Holmes Swan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2025 | 191 | 191 | - | - | Restricted Stock Units | |
| Nike | Robert Holmes Swan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2025 | 2,619 | 34,602 (0%) | 0% | 0 | Class B Common Stock | |
| Repay Holdings Corp (Class A) | Robert Scott Houser | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2025 | 118,243 | 118,243 (0%) | 0% | 0 | Class A Common Stock | |
| Commerce Bancshares Inc | Robert S. Holmes | Executive Vice President | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Sep 2025 | 470 | 56,804 (0%) | 0% | 0 | Common Stock | |
| Northwestern Corp | Jan Robert Horsfall | Director | Grant, award, or other acquisition of securities at price $ 51.30 per share. | 01 Aug 2025 | 731 | 9,232 (0%) | 0% | 51.3 | 37,500 | Common Stock |
| Manhattan Associates Inc | Robert G. Howell | EVP, Americas Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2025 | 2,808 | 160,545 (0%) | 0% | 0 | Common Stock | |
| Micron Tech | Robert Holmes Swan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 250 | 250 | - | - | Restricted Stock Units | |
| FibroBiologics Inc | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Nextdoor Holdings Inc (Class A) | Robert Hohman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 106,707 | 106,707 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Robert Hohman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 9,018 | 0 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Robert Hohman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 9,018 | 369,994 | - | 0 | Class A Common Stock | |
| MarketAxess Holdings Inc | Roberto Hoornweg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 784 | 999 (0%) | 0% | 0 | Common Stock, par value $0.003 per share | |
| Esperion Therapeutics Inc | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 7,040 | 7,040 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 5,280 | 5,280 (0%) | 0% | 0 | Common Stock | |
| Biomarin pharma Inc - Registered Shares | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 6,650 | 41,870 (0%) | 0% | 0 | Common Stock | |
| Meridian Corp | Robert T. Holland | Director | Purchase of securities on an exchange or from another person at price $ 14.30 per share. | 19 May 2025 | 545 | 77,552 (1%) | 0% | 14.3 | 7,795 | COMMON STOCK |
| Meridian Corp | Robert T. Holland | Director | Purchase of securities on an exchange or from another person at price $ 14.35 per share. | 19 May 2025 | 54 | 77,007 (1%) | 0% | 14.4 | 775 | COMMON STOCK |
| Meridian Corp | Robert T. Holland | Director | Purchase of securities on an exchange or from another person at price $ 15.62 per share. | 19 May 2025 | 8 | 1,008 (0%) | 0% | 15.6 | 125 | COMMON STOCK |
| Empire State Realty Trust Inc (Class A) | Robert Paige Hood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 16,484 | 156,333 | - | - | LTIP Units | |
| Empire State Realty Trust Inc (Class A) | Robert Paige Hood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 13,352 | 169,685 | - | - | LTIP Units | |
| Rallybio Corp | Robert Hopfner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 28,500 | 28,500 | - | - | Option (Right to Buy) | |
| Northwestern Corp | Jan Robert Horsfall | Director | Grant, award, or other acquisition of securities at price $ 57.87 per share. | 02 May 2025 | 648 | 8,483 (0%) | 0% | 57.9 | 37,500 | Common Stock |
| Nextdoor Holdings Inc (Class A) | Robert Hohman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 60,976 | 60,975 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Robert Hohman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 60,976 | 360,976 | - | 0 | Class A Common Stock | |
| Nike | Robert Holmes Swan | Director | Purchase of securities on an exchange or from another person at price $ 58.46 per share. | 04 Apr 2025 | 8,600 | 31,983 (0%) | 0% | 58.5 | 502,756 | Class B Common Stock |
| Esperion Therapeutics Inc | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Micron Tech | Robert Holmes Swan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 353 | 353 | - | - | Restricted Stock Units | |
| CF Bankshares Inc | Robert E. Hoeweler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 5,000 | 71,062 (1%) | 0% | 0 | Common Stock 12520L 109 | |
| Century Aluminum Co. | Robert F. Hoffman | SVP, IT and CAO | Sale of securities on an exchange or to another person at price $ 20.24 per share. | 20 Mar 2025 | 5,000 | 59,083 (0%) | 0% | 20.2 | 101,200 | Common Stock |
| CNA Fin Corp | Robert Joseph Hopper | EVP & Chief Actuary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 20,962 | 88,353 (0%) | 0% | 0 | Common Stock | |
| CNA Fin Corp | Robert Joseph Hopper | EVP & Chief Actuary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.55 per share. | 15 Mar 2025 | 9,675 | 78,678 (0%) | 0% | 48.5 | 469,721 | Common Stock |
| Century Aluminum Co. | Robert F. Hoffman | SVP, IT and CAO | Sale of securities on an exchange or to another person at price $ 19.99 per share. | 14 Mar 2025 | 2,500 | 64,083 (0%) | 0% | 20.0 | 49,975 | Common Stock |
| CF Bankshares Inc | Robert E. Hoeweler | Director | Purchase of securities on an exchange or from another person at price $ 21.80 per share. | 11 Mar 2025 | 1,000 | 66,062 (1%) | 0% | 21.8 | 21,801 | Common Stock 12520L 109 |
| American Tower | Robert D. Hormats | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 1,056 | 8,388 (0%) | 0% | 0 | Common Stock | |
| Henry Schein | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 2,844 | 2,844 (0%) | 0% | 0 | Common Stock par value $0.01 per share | |
| CF Bankshares Inc | Robert E. Hoeweler | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2025 | 800 | 65,262 (1%) | 0% | 0 | Common Stock 12520L 109 | |
| CF Bankshares Inc | Robert E. Hoeweler | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2025 | 200 | 65,062 (1%) | 0% | 0 | Common Stock 12520L 109 | |
| Nextdoor Holdings Inc (Class A) | Robert Hohman | Director | Purchase of securities on an exchange or from another person at price $ 1.65 per share. | 03 Mar 2025 | 200,000 | 300,000 | - | 1.7 | 330,980 | Class A Common Stock |
| Nextdoor Holdings Inc (Class A) | Robert Hohman | Director | Purchase of securities on an exchange or from another person at price $ 1.68 per share. | 03 Mar 2025 | 100,000 | 100,000 | - | 1.7 | 168,500 | Class A Common Stock |
| MarketAxess Holdings Inc | Roberto Hoornweg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 215 | 215 (0%) | 0% | 0 | Common Stock, par value $0.003 per share | |
| Manhattan Associates Inc | Robert G. Howell | EVP, Americas Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 176.88 per share. | 28 Feb 2025 | 525 | 157,737 (0%) | 0% | 176.9 | 92,862 | Common Stock |
| Embecta Corp | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 13,839 | 39,749 | - | 0 | Common Stock | |
| Northwestern Corp | Jan Robert Horsfall | Director | Grant, award, or other acquisition of securities at price $ 53.46 per share. | 05 Feb 2025 | 702 | 7,827 (0%) | 0% | 53.5 | 37,529 | Common Stock |
| Commerce Bancshares Inc | Robert S. Holmes | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.87 per share. | 03 Feb 2025 | 1,848 | 57,274 (0%) | 0% | 65.9 | 121,728 | Common Stock |
| Manhattan Associates Inc | Robert G. Howell | EVP, Americas Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 208.59 per share. | 31 Jan 2025 | 7,109 | 158,262 (0%) | 0% | 208.6 | 1,482,866 | Common Stock |
| Commerce Bancshares Inc | Robert S. Holmes | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 6,316 | 59,122 (0%) | 0% | 0 | Common Stock | |
| Manhattan Associates Inc | Robert G. Howell | EVP, Americas Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 5,825 | 157,767 (0%) | 0% | 0 | Common Stock | |
| Manhattan Associates Inc | Robert G. Howell | EVP, Americas Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 4,656 | 162,423 (0%) | 0% | 0 | Common Stock | |
| Manhattan Associates Inc | Robert G. Howell | EVP, Americas Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 2,948 | 165,371 (0%) | 0% | 0 | Common Stock | |
| Cal-Maine Foods Inc | Robert L. Holladay | VP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2025 | 1,113 | 17,078 (0%) | 0% | 0 | Common Stock | |
| Cal-Maine Foods Inc | Robert L. Holladay | VP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 109.97 per share. | 14 Jan 2025 | 789 | 15,965 (0%) | 0% | 110.0 | 86,766 | Common Stock |
| Rallybio Corp | Robert Hopfner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 73,571 | 73,571 | - | - | Option (Right to Buy) | |
| TuHURA Biosciences Inc | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 51,275 | 51,275 | - | - | Options (Right to Buy) | |
| Century Aluminum Co. | Robert F. Hoffman | SVP, IT and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 13,723 | 65,579 (0%) | 0% | 0 | Common Stock | |
| Century Aluminum Co. | Robert F. Hoffman | SVP, IT and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 8,257 | 66,583 (0%) | 0% | 0 | Common Stock | |
| Century Aluminum Co. | Robert F. Hoffman | SVP, IT and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.22 per share. | 31 Dec 2024 | 5,401 | 60,178 (0%) | 0% | 18.2 | 98,406 | Common Stock |
| Century Aluminum Co. | Robert F. Hoffman | SVP, IT and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.22 per share. | 31 Dec 2024 | 1,852 | 58,326 (0%) | 0% | 18.2 | 33,743 | Common Stock |
| Micron Tech | Robert Holmes Swan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 366 | 4,444 (0%) | 0% | 0 | Common Stock | |
| Affinity Bancshares Inc | Howard G. Roberts | Director | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 20 Nov 2024 | 134 | 23,941 | - | 21.5 | 2,881 | Common Stock |
| Affinity Bancshares Inc | Howard G. Roberts | Director | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 19 Nov 2024 | 703 | 24,075 | - | 21.5 | 15,115 | Common Stock |
| Affinity Bancshares Inc | Howard G. Roberts | Director | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 06 Nov 2024 | 3,829 | 28,172 | - | 21.5 | 82,324 | Common Stock |
| Affinity Bancshares Inc | Howard G. Roberts | Director | Sale of securities on an exchange or to another person at price $ 21.51 per share. | 06 Nov 2024 | 1,453 | 26,719 | - | 21.5 | 31,253 | Common Stock |
| Affinity Bancshares Inc | Howard G. Roberts | Director | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 06 Nov 2024 | 1,346 | 25,373 | - | 21.5 | 28,940 | Common Stock |
| Affinity Bancshares Inc | Howard G. Roberts | Director | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 06 Nov 2024 | 222 | 25,151 | - | 21.5 | 4,773 | Common Stock |
| Affinity Bancshares Inc | Howard G. Roberts | Director | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 06 Nov 2024 | 142 | 24,880 | - | 21.5 | 3,053 | Common Stock |
| Affinity Bancshares Inc | Howard G. Roberts | Director | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 06 Nov 2024 | 129 | 25,022 | - | 21.5 | 2,774 | Common Stock |
| Affinity Bancshares Inc | Howard G. Roberts | Director | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 06 Nov 2024 | 102 | 24,778 | - | 21.5 | 2,193 | Common Stock |
| Micron Tech | Robert Holmes Swan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2024 | 2,338 | 4,078 (0%) | 0% | 0 | Common Stock | |
| Northwestern Corp | Jan Robert Horsfall | Director | Grant, award, or other acquisition of securities at price $ 57.22 per share. | 01 Oct 2024 | 688 | 7,125 (0%) | 0% | 57.2 | 39,367 | Common Stock |
| Micron Tech | Robert Holmes Swan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 291 | 1,740 (0%) | 0% | 0 | Common Stock | |
| Nike | Robert Holmes Swan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 2,437 | 23,383 (0%) | 0% | 0 | Class B Common Stock | |
| FibroBiologics Inc | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Cal-Maine Foods Inc | Robert L. Holladay | VP - General Counsel | Sale of securities on an exchange or to another person at price $ 70.93 per share. | 20 Aug 2024 | 1,500 | 16,754 (0%) | 0% | 70.9 | 106,397 | Common Stock |
| Nextdoor Holdings Inc (Class A) | Robert Hohman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 121,951 | 121,951 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Robert Hohman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 9,018 | 9,018 | - | - | Restricted Stock Units (RSU) | |
| Commerce Bancshares Inc | Robert S. Holmes | Executive Vice President | Sale or transfer of securities back to the company at price $ 64.79 per share. | 25 Jul 2024 | 8,352 | 54,088 (0%) | 0% | 64.8 | 541,126 | Common Stock |
| Commerce Bancshares Inc | Robert S. Holmes | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.53 per share. | 25 Jul 2024 | 5,981 | 67,854 (0%) | 0% | 47.5 | 284,269 | Common Stock |
| Commerce Bancshares Inc | Robert S. Holmes | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2024 | 5,981 | 0 | - | - | Stock Appreciation Rights | |
| Commerce Bancshares Inc | Robert S. Holmes | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.99 per share. | 25 Jul 2024 | 5,838 | 61,873 (0%) | 0% | 44.0 | 256,810 | Common Stock |
| Commerce Bancshares Inc | Robert S. Holmes | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2024 | 5,838 | 0 | - | - | Stock Appreciation Rights | |
| Commerce Bancshares Inc | Robert S. Holmes | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.17 per share. | 25 Jul 2024 | 5,742 | 56,035 (0%) | 0% | 40.2 | 230,684 | Common Stock |